ARX:ASX
Aroa Biosurgery Ltd
0,50 A$
arrow_upward
+1,01%(+0,0050) 1D
6 հոկ, 16:10:29 GMT+11 · AUD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for ARX...
Open
0,51 A$
High
0,51 A$
Low
0,50 A$
Mkt. cap
171,22 մլն
Avg. vol.
173,54 հզր
Volume
460,91 հզր
P/E ratio
48,03
52-wk high
0,80 A$
52-wk low
0,48 A$
EPS
0,01 A$
Shares outstanding
345,90 մլն
No. of employees
261
Open
0,51 A$
High
0,51 A$
Low
0,50 A$
Mkt. cap
171,22 մլն
Avg. vol.
173,54 հզր
Volume
460,91 հզր
P/E ratio
48,03
52-wk high
0,80 A$
52-wk low
0,48 A$
EPS
0,01 A$
Shares outstanding
345,90 մլն
No. of employees
261
News stories
From web sources and news partners
BusinessDesk | NZ
·
2 ժամ առաջ
Aroa's Symphony potential not priced in, Bell Potter says
Kalkine Media
·
13 ժամ առաջ
ASX Healthcare Stock Aroa Biosurgery (ASX:ARX) Has the Market Watching
Profile
Aroa Biosurgery Limited is a regenerative medicine company that develops, manufactures and distributes products for wound healing and soft tissue reconstruction. Aroa Biosurgery is headquartered in Auckland, New Zealand with a US office in San Diego, CA, and is listed on the Australian Securities Exchange.
The company, originally known as Mesynthes Limited, was founded in 2008 by Veterinarian Surgeon Dr Brian Ward. The company develops and commercializes products based on its proprietary ovine forestomach matrix technology platform with products in wound healing as well as plastics and reconstructive surgery and repair of hernia. Wikipedia
About Aroa Biosurgery Ltd